– Cloud-Based AI Image Analysis Platform “CarbConnect^®” Integrated Application –
– Streamlining Antimicrobial Susceptibility Testing with Immediate CLSI-Based SIR Results –

Tokyo, Japan – February　26, 2025 – CarbGeM Inc. (Head Office: Shibuya-ku, Tokyo; CEO: Masakazu Nakajima) has launched “ZOI Pro,” a new application integrated with the cloud-based AI image analysis platform “CarbConnect^®.” The app automates the measurement of the Zone of Inhibition (ZOI) in disk diffusion tests and simultaneously displays antimicrobial susceptibility results based on the Clinical and Laboratory Standards Institute (CLSI) guidelines.

“ZOI Pro” automates what was traditionally a manual process using calipers and rulers, thanks to AI image analysis technology. By inputting bacterial and antibiotic names, users can instantly view SIR (Susceptible, Intermediate, Resistant) results based on data from the CLSI’s Performance Standards for Antimicrobial Susceptibility Testing, 34th Edition (2024). This significantly reduces the workload of researchers and medical professionals, contributing to operational efficiency and standardization.

ZOI Pro – Zone of Inhibition – measurement

About ZOI Pro

Development Background:
The measurement of the zone of inhibition is essential for research and diagnostic purposes in antimicrobial susceptibility testing. However, manual measurements are time-consuming and prone to variability depending on the operator. “ZOI Pro” leverages AI image analysis to streamline and standardize this process, enabling researchers to obtain accurate and consistent results.

By integrating with CarbConnect^®, all measurement data and images can be securely stored and shared on the cloud. This enables seamless real-time collaboration among researchers and remote teams.

Key Features

• AI-Powered Automatic ZOI Measurement:
  Automates the measurement of the inhibition zone in disk diffusion tests using AI image analysis, ensuring rapid^* and highly accurate results while eliminating inconsistencies caused by manual measurements.
• SIR (Susceptible, Intermediate, Resistant) Judgment Function:
  By entering bacterial and antibiotic names, the app automatically displays SIR results based on CLSI’s 34th Edition (2024), allowing for immediate confirmation of test outcomes.
• Seamless Data Management:
  Integration with CarbConnect^® enables secure storage and sharing of measurement data, facilitating real-time collaboration among research teams and experts in different locations.
• Manual Adjustment Function:
  Post-analysis manual adjustments can be made to fine-tune the results, ensuring the highest level of accuracy.
• Pricing:
  USD 7.00 /month

*Response Time: Approximately 2 seconds (may vary depending on network conditions)

For more details about ZOI Pro, visit:
https://www.carb-connect.com/applications/ZOI_PRO

Anticipated Use Cases

• Medical & Research Institutions:
  Supports the standardization of antimicrobial susceptibility testing, enabling quick and accurate data acquisition.
• Education & Training:
  Acts as a learning tool for students and new researchers in educational institutions and laboratory settings, facilitating effective training.
• Remote & Collaborative Research:
  Facilitates smooth data sharing and collaborative research with remote teams using the CarbConnect^® platform.

About CarbConnect^®

CarbConnect^® facilitates secure image storage, real-time communication, and seamless collaboration among experts, even in remote environments. By enabling image-driven workflows across PCs, smartphones, and tablets, the platform supports imaging applications in research, medical, and other professional fields.

For more details, please visit: CarbConnect Details
Register for CarbConnect^® here: https://www.carb-connect.com/create-account

Future Outlook

CarbGeM Inc. aims to enhance the accuracy and efficiency of antimicrobial susceptibility testing through the introduction of “ZOI Pro”. The company will continue to strengthen its integration with the CarbConnect^® platform and develop next-generation research support tools that leverage advanced AI image analysis technologies.

About CarbGeM Inc.

CarbGeM Inc. is committed to applying its proprietary AI analysis technologies to combat bacterial infections through the convergence of biology and digital innovation. Through open innovation with leading domestic and international research institutions, the company aims to address global challenges, such as antimicrobial resistance.

Headquarters: 1-5-13 Jinnan, Shibuya, Tokyo

CEO: Masakazu Nakajima

Website: https://carbgem.com/en/